Answers are grounded in this paper and cite their sources.
We have examined primary leukemia cells from multiple myeloma and plasma-cell leukemia patients for rearrangement, amplification and expression of c-myc oncogene. No rearrangement or detectable amplification of the c-myc could be found in 21 cases of multiple myeloma. In contrast, 2/3 cases of plasma-cell leukemia showed amplification of the oncogene with concomitant higher level of expression.
No takes yet. Share an insight, caveat, or question.
Sümegi et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: